TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
EVMN

Evommune, Inc.

Healthcare · Biotechnology

8.80$ -8.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement EVMN
Line item 2023 2024 2025
– +40.0% +85.7%
– +28.7% +7.9%
– +42.8% +127.6%
– +100.8% +15.3%
– – –
– +80.9% +24.2%
– – –
– -41.4% -79.4%
– – –
– – –
– – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?